Home › Neuroblastoma › Hawaii › Honolulu
Neuroblastoma clinical trials in Honolulu, HI
6 studies for Neuroblastoma are looking for participants at sites in and around Honolulu (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RecruitingPhase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Kapiolani Medical Center for Women and Children, Honolulu
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RecruitingPhase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RecruitingPhase 2
- Kapiolani Medical Center for Women and Children, Honolulu
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- Kapiolani Medical Center for Women and Children, Honolulu
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RecruitingPhase 2
- Kapiolani Medical Center for Women and Children, Honolulu
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- New York City, NY12 studies
- Washington, DC11 studies
- Dallas, TX10 studies
- Cincinnati, OH9 studies
- St. Louis, MO9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Aurora, CO9 studies
- Hartford, CT8 studies
- Birmingham, AL8 studies
- Harrisburg, PA8 studies
Other studies in Honolulu
- Obesity14 studies
- Cancer (all types)13 studies
- Overweight13 studies
- Non-Small Cell Lung Cancer12 studies
- Breast Cancer11 studies
- Type 2 Diabetes8 studies
- Lung Cancer8 studies
- Ovarian Cancer7 studies
- Pancreatic Cancer7 studies
- Metastatic Cancer6 studies
- Prostate Cancer6 studies
- Acute Myeloid Leukemia6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.